Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere–cationic folate nanoconjugate
Source abstract
Abstract
FRs. A doxorubicin-associated FR-targeting formulation (CFD), in an orthotopic glioma model and in a glioma subcutaneous model, induced the maximum anticancer effect with enhanced average mice survivability twice that of untreated mice and without any systemic liver toxicity. Additionally, we observed a significant decrease of TAM-released pro-aggressive factors, TGF-β, STAT3, invasion and migration related sICAM-1, and other cytokines indicating anti-TAM activity of the CFD. Taken together, we principally devised, to the best of our knowledge, the first FR-targeting nano-delivery system for targeting brain-associated TAMs and tumor cells as an efficient glioma therapeutic.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Immune cells in cancer · MicroRNA in disease regulation · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Applied Biology Division
CSIR-Indian Institute of Chemical Technology
Hyderabad
India
Academy of Scientific & Innovative Research (AcSIR)
Department of Biological Sciences
Chemistry and Physics of Materials Unit
Jawaharlal Nehru Centre for Advanced Scientific Research
Bangalore
Transcription and Disease Laboratory
Molecular Biology and Genetics Unit
BITS Pilani
Hyderabad 500078
References (50)
Show source-provided references
1. Bai · Trends Mol. Med. · 2011 · 17 · 30110.1016/j.molmed.2011.01.011 ↗
2. Lewis · Cancer Res. · 2006 · 66 · 60510.1158/0008-5472.CAN-05-4005 ↗
3. Elgert · J. Leukocyte Biol. · 1998 · 64 · 27510.1002/jlb.64.3.275 ↗
4. Sunderkötter · Pharmacol. Ther. · 1991 · 51 · 19510.1016/0163-7258(91)90077-Y ↗
5. Zhou · Nat. Cell Biol. · 2015 · 17 · 17010.1038/ncb3090 ↗
6. Murdoch · Blood · 2004 · 104 · 222410.1182/blood-2004-03-1109 ↗
7. Pyonteck · Nat. Med. · 2013 · 19 · 126410.1038/nm.3337 ↗
8. Quail · Science · 2016 · 352
9. Chong · J. Cell. Physiol. · 1999 · 178 · 27510.1002/(SICI)1097-4652(199903)178:3<275::AID-JCP1>3.0.CO;2-Q ↗
10. Wan · Gastroenterology · 2014 · 147 · 139310.1053/j.gastro.2014.08.039 ↗
11. Miller · Nat. Commun. · 2015 · 6 · 869210.1038/ncomms9692 ↗
12. Zhang · Chem. Commun. · 2015 · 51 · 924610.1039/C5CC01759A ↗
13. Nieto-Márquez · J. Mater. Chem. · 2011 · 21 · 166410.1039/C0JM01350A ↗
14. Selvi · Nano Lett. · 2008 · 8 · 318210.1021/nl801503m ↗
15. Saul · J. Controlled Release · 2003 · 92 · 4910.1016/S0168-3659(03)00295-5 ↗
16. Puig-Kröger · Cancer Res. · 2009 · 69 · 939510.1158/0008-5472.CAN-09-2050 ↗
17. Cheng · Biomaterials · 2012 · 33 · 117010.1016/j.biomaterials.2011.10.057 ↗
18. Chen · ACS Appl. Mater. Interfaces · 2014 · 6 · 1985010.1021/am505223t ↗
19. Chen · J. Controlled Release · 2015 · 211 · 5310.1016/j.jconrel.2015.05.288 ↗
20. Gao · Sci. Rep. · 2013 · 3 · 253410.1038/srep02534 ↗
21. Wang · Adv. Funct. Mater. · 2016 · 26 · 787310.1002/adfm.201602810 ↗
22. Zeng · Adv. Funct. Mater. · 2016 · 26 · 420110.1002/adfm.201600642 ↗
23. Elechalawar · Biomater. Sci. · 2017 · 5 · 189810.1039/C7BM00405B ↗
24. Okada · Int. J. Cancer · 1998 · 78 · 19610.1002/(SICI)1097-0215(19981005)78:2<196::AID-IJC13>3.0.CO;2-9 ↗
25. Cassetta · Adv. Exp. Med. Biol. · 2016 · 21110.1007/978-3-319-26666-4_12 ↗
26. Laoui · Bio-Protoc. · 2014 · 4 · e129410.21769/BioProtoc.1294 ↗
27. Quatromoni · Am. J. Transl. Res. · 2012 · 4 · 376
28. Noy · Immunity · 2014 · 41 · 4910.1016/j.immuni.2014.06.010 ↗
29. Hao · Clin. Dev. Immunol. · 2012 · 2012
30. Panse · Br. J. Cancer · 2008 · 99 · 93010.1038/sj.bjc.6604621 ↗
31. Nitta · Oncol. Rep. · 2014 · 32 · 171510.3892/or.2014.3341 ↗
32. Rosette · Carcinogenesis · 2005 · 26 · 94310.1093/carcin/bgi070 ↗
33. Teicher · Clin. Cancer Res. · 2010 · 16 · 292710.1158/1078-0432.CCR-09-2329 ↗
34. Gong · PLoS One · 2013 · 8 · e7736610.1371/journal.pone.0077366 ↗
35. Voronov · Proc. Natl. Acad. Sci. · 2003 · 100 · 264510.1073/pnas.0437939100 ↗
36. Perrier · FEBS Lett. · 2006 · 580 · 628910.1016/j.febslet.2006.10.061 ↗
37. Belperio · J. Leukocyte Biol. · 2000 · 68 · 110.1189/jlb.68.1.1 ↗
38. Kajitani · Breast Cancer Res. Treat. · 2012 · 134 · 13910.1007/s10549-011-1944-x ↗
39. Kumar · Nature · 2007 · 448 · 3910.1038/nature05901 ↗
40. Son · J. Controlled Release · 2011 · 155 · 1810.1016/j.jconrel.2010.08.011 ↗
41. Zhan · Mol. Pharm. · 2010 · 7 · 194010.1021/mp100238j ↗
42. Wei · Angew. Chem., Int. Ed. · 2015 · 54 · 302310.1002/anie.201411226 ↗
43. Desgrosellier · Nat. Rev. Cancer · 2010 · 10 · 910.1038/nrc2748 ↗
44. Miura · ACS Nano · 2013 · 7 · 858310.1021/nn402662d ↗
45. Martinez · Annu. Rev. Immunol. · 2009 · 27 · 45110.1146/annurev.immunol.021908.132532 ↗
46. Georgoudaki · Cell Rep. · 2016 · 15 · 200010.1016/j.celrep.2016.04.084 ↗
47. Wu · Pharm. Res. · 1999 · 16 · 41510.1023/A:1018829920158 ↗
48. Varghese · Mol. Pharm. · 2007 · 4 · 67910.1021/mp0700615 ↗
49. Lu · Adv. Drug Delivery Rev. · 2004 · 56 · 116110.1016/j.addr.2004.01.009 ↗
50. Xia · Blood · 2009 · 113 · 43810.1182/blood-2008-04-150789 ↗